Michael LaRiviere, MD
Radiation Oncology
Accepting new patients
Sees patients of all ages
Penn Radiation Oncology Perelman - 2nd Floor
Penn Medicine Provider

About me

  • Assistant Professor of Radiation Oncology at the Hospital of the University of Pennsylvania

Education and training

  • Medical School: Emory University
  • Residency: Hospital of the University of Pennsylvania

What my patients think about me

Average Rating

73 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

October 2025
took the time to explain everything and all risks associated with treatment. answered all questions
October 2025
sufficient
October 2025
he was attentive knowledgeable and had a pleasant bedside manner.
September 2025
very nice and detailed

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. LaRiviere is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Yegya-Raman, Nikhil, Plastaras, John P, Wright, Christopher M, Chelius, Monica, Zhang, Siqi, Baron, Jonathan A, Hubbeling, Harper, Sim, Austin J, Robinson, Timothy J, Jain, Michael D Bridging radiotherapy before chimeric antigen receptor T cells for B-cell lymphomas: an ILROG multicenter study , Blood Advances, 9(13): 2025,3293-3303


Dreyfuss, AD, Ganesan, N, Imber, BS, LaRiviere, M, Isrow, D, Plastaras, J, Svoboda, J, Yahalom, J, Moskowitz, CH, Moskowitz, A PEMBROLIZUMAB AND RADIATION THERAPY ALONE AS AN ALTERNATIVE TO TRANSPLANT FOR LOCALIZED FAILURE AFTER CHEMOTHERAPY IN HODGKIN LYMPHOMA: A MULTICENTER PHASE II STUDY , Hematological Oncology, 43: 2025,e129_70093


Elghawy, Omar, Sussman, Jonathan H, Yang, Austin G, Thomas, Colin J, Carter, Jordan S, Landsburg, Daniel J, Svoboda, Jakub, Kim, Ellen, Rook, Alain H, Chung, Jina Pembrolizumab in Relapsed or Refractory Mycosis Fungoides or Sézary Syndrome , JAMA dermatology, 161(6): 2025,656-658


Elghawy, Omar, Yang, Austin G, Sussman, Jonathan H, Thomas, Colin J, Carter, Jordan S, Landsburg, Daniel J, Svoboda, Jakub, Kim, Ellen, Rook, Alain H, Chung, Jina Retrospective cohort study of novel oral agents lenalidomide and duvelisib for relapsed or refractory mycosis fungoides and Sézary syndrome , Journal of the American Academy of Dermatology, 92(3): 2025,634-636


Zhu, Yifeng, Lu, Baozhu, Byrd, Brook, Chen, Lisha, Xiong, Emily, Plastaras, John P, LaRiviere, Michael, Pogue, Brian W, Zhu, Timothy C Assessment of generic corrections for multiview Cherenkov emission during total skin electron therapy (TSET) , Proc SPIE Int Soc Opt Eng, 13299: 2025,24-32


Howell, Jackson N, Mark, Bayarmaa, Wada, David A, Bowling, Marianne, Wei, Mei, Lloyd, Shane L, Gaffney, David K, Maity, Amit, LaRiviere, Michael J, Rule, William G Mental Health Diagnoses in Patients With Mycosis Fungoides and Potential Impact on Oncologic Outcomes , Cancer Medicine, 14(5): 2025,e70577


Hollawell, Casey, Zhang, Siqi, Santos, Alexis Girón, MacDuffie, Emily, Friedes, Cole, Eisenberg, Rachel, Feigenberg, Steven, Konski, Andre, Khullar, Karishma, Maxwell, Russell Patterns and disparities of proton therapy utilization among adult cancer patients , International Journal of Particle Therapy, 15: 2025,100680


Jiang C, Kim M, Han X, Chelius M, Hoover T, Kersun L, Reilly AF, Hubbeling H, Cummings E, Kurtz G, Hill-Kayser C, Plastaras JP, LaRiviere MJ Outcomes of proton therapy to infradiaphragmatic sites in pediatric patients with Hodgkin lymphoma , Pediatric Blood & Cancer, 71(12): 2024,e31290


Kostopoulos N, Costabile F, Krimitza E, Beghi S, Goia D, Perales-Linares R, Thyfronitis G, LaRiviere MJ, Chong EA, Schuster SJ, Maity A, Koumenis C, Plastaras JP, Facciabene A Local Radiation Enhances Systemic CAR T Cell Efficacy by Augmenting Antigen Cross-Presentation and T-cell Infiltration , Blood Advances, 8(24): 2024,6308-6320


Dreyfuss A, Ganesan N, Alencar AJ, Boardman AP, Caron P, Chang T, Davey T, David KA, Dogan A, Epstein-Peterson ZD, Falchi L, Fregonese B, Ghione P, Hamlin PA, Horowitz S, Imber BS, Intlekofer AM, Isrow D, Joffe E, Johnson WT, Kumar A, LaRiviere M, Lue JK, Luttwak A, McNicholas M, Moore Z, Munayirji B, Noy A, Owens C, Palomba ML, Patel J, Plastaras JP, Santarosa AM, Schoder H, Shah GL, Steiner RE, Stuver R, Svoboda Jm Torka P, Vardhana SA, Zelenetz AD, Salles G, Yahalom J, Moskowitz CH, Moskowitz A Pembrolizumab and Involved Site Radiation Therapy Alone As an Alternative to Transplant in Patients with Localized Failure Following Chemotherapy for Hodgkin Lymphoma: A Prospective Multicenter Phase II Study , Blood, 144(Suppl1): 2024,4434


View all publications